The authors discuss various nanomedicines designed to selectively target breast cancer, triple negative breast cancer, and breast cancer stem cells.
[International Journal of Molecular Sciences]
6807162
ZB649UEY
items
1
apa
0
default
asc
1
161894
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-3116819e143472400535eaa4b0469e46%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZB649UEY%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gote%20et%20al.%22%2C%22parsedDate%22%3A%222021-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGote%2C%20V.%2C%20Nookala%2C%20A.%20R.%2C%20Bolla%2C%20P.%20K.%2C%20%26amp%3B%20Pal%2C%20D.%20%282021%29.%20Drug%20Resistance%20in%20Metastatic%20Breast%20Cancer%3A%20Tumor%20Targeted%20Nanomedicine%20to%20the%20Rescue.%20%3Ci%3EInternational%20Journal%20of%20Molecular%20Sciences%3C%5C%2Fi%3E%2C%20%3Ci%3E22%3C%5C%2Fi%3E%289%29%2C%204673.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms22094673%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms22094673%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DZB649UEY%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Drug%20Resistance%20in%20Metastatic%20Breast%20Cancer%3A%20Tumor%20Targeted%20Nanomedicine%20to%20the%20Rescue%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vrinda%22%2C%22lastName%22%3A%22Gote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anantha%20Ram%22%2C%22lastName%22%3A%22Nookala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pradeep%20Kumar%22%2C%22lastName%22%3A%22Bolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhananjay%22%2C%22lastName%22%3A%22Pal%22%7D%5D%2C%22abstractNote%22%3A%22Breast%20cancer%2C%20specifically%20metastatic%20breast%2C%20is%20a%20leading%20cause%20of%20morbidity%20and%20mortality%20in%20women.%20This%20is%20mainly%20due%20to%20relapse%20and%20reoccurrence%20of%20tumor.%20The%20primary%20reason%20for%20cancer%20relapse%20is%20the%20development%20of%20multidrug%20resistance%20%28MDR%29%20hampering%20the%20treatment%20and%20prognosis.%20MDR%20can%20occur%20due%20to%20a%20multitude%20of%20molecular%20events%2C%20including%20increased%20expression%20of%20efflux%20transporters%20such%20as%20P-gp%2C%20BCRP%2C%20or%20MRP1%3B%20epithelial%20to%20mesenchymal%20transition%3B%20and%20resistance%20development%20in%20breast%20cancer%20stem%20cells.%20Excessive%20dose%20dumping%20in%20chemotherapy%20can%20cause%20intrinsic%20anti-cancer%20MDR%20to%20appear%20prior%20to%20chemotherapy%20and%20after%20the%20treatment.%20Hence%2C%20novel%20targeted%20nanomedicines%20encapsulating%20chemotherapeutics%20and%20gene%20therapy%20products%20may%20assist%20to%20overcome%20cancer%20drug%20resistance.%20Targeted%20nanomedicines%20offer%20innovative%20strategies%20to%20overcome%20the%20limitations%20of%20conventional%20chemotherapy%20while%20permitting%20enhanced%20selectivity%20to%20cancer%20cells.%20Targeted%20nanotheranostics%20permit%20targeted%20drug%20release%2C%20precise%20breast%20cancer%20diagnosis%2C%20and%20importantly%2C%20the%20ability%20to%20overcome%20MDR.%20The%20article%20discusses%20various%20nanomedicines%20designed%20to%20selectively%20target%20breast%20cancer%2C%20triple%20negative%20breast%20cancer%2C%20and%20breast%20cancer%20stem%20cells.%20In%20addition%2C%20the%20review%20discusses%20recent%20approaches%2C%20including%20combination%20nanoparticles%20%28NPs%29%2C%20theranostic%20NPs%2C%20and%20stimuli%20sensitive%20or%20%5Cu201csmart%5Cu201d%20NPs.%20Recent%20innovations%20in%20microRNA%20NPs%20and%20personalized%20medicine%20NPs%20are%20also%20discussed.%20Future%20perspective%20research%20for%20complex%20targeted%20and%20multi-stage%20responsive%20nanomedicines%20for%20metastatic%20breast%20cancer%20is%20discussed.%22%2C%22date%22%3A%222021%5C%2F1%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms22094673%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1422-0067%5C%2F22%5C%2F9%5C%2F4673%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-05-04T20%3A29%3A48Z%22%7D%7D%5D%7D
Gote, V., Nookala, A. R., Bolla, P. K., & Pal, D. (2021). Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences, 22(9), 4673. https://doi.org/10.3390/ijms22094673 Cite
